Deep Dive

Market Access

How to solve a problem like DTx in Europe?

The promise of digital therapeutics (DTx) has been widely discussed and debated since the term first began to emerge back in the early 2010s.

Market Access

CSL opens a new R&D facility in Waltham, Massachusetts

On March 27th, global biopharma company CSL opened a new R&D facility in Waltham, Massachusetts.

Market Access

What the HRT is happening with menopause care in the UK?

Menopause is a natural process that occurs as women age and marks the end of their reproductive years.

R&D

Around the world in pharma events

Stay up to date with key industry meetings and conferences in 2023 Americas FT US Pharma & Biotech Summit 16-17-May New York, US

R&D

Heard on the pipeline: R&D in the pharma industry

In the fast-paced world of healthcare, it can take a lot of work to keep up-to-date with the numerous innovations, trends, and opinions that emerge each year.

R&D

What’s next for oncology research?

Eliminating cancer as a cause of death is a highly ambitious goal, but oncology researchers are showing no signs of giving up the fight in 2023.

How to solve a problem like DTx in Europe?

CSL opens a new R&D facility in Waltham, Massachusetts

What the HRT is happening with menopause care in the UK?

Around the world in pharma events

Heard on the pipeline: R&D in the pharma industry

What’s next for oncology research?

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

Deep Dive

Editor's Picks